Optellum partners, GE Healthcare, have published an insights article about Optellum's Virtual Nodule Clinic and the advantages clinicians have seen from using the system. “People are coming to emergency rooms…
Clinicians from top US healthcare centers demonstrate the benefits of AI-assisted early lung cancer diagnosis at this year’s American Thoracic Society (ATS) International Conference. WASHINGTON, D.C. (#ATS2023, booth 2521) —…
Vaclav joined TechRound editor to talk about how Optellum has evolved since being founded to becoming the leader in AI diagnosis. My aunt was diagnosed and passed away from lung…
AtlantiCare joined leading healthcare systems worldwide by becoming the first system in the northeastern U.S. to use the Optellum Virtual Nodule Clinic. EGG HARBOR TOWNSHIP, N.J., Feb. 23, 2023 /PRNewswire/ -- AtlantiCare is the…
Jason joined Natalie Harms, the editor of Innovation Map, to talk about Optellum's journey and his career as a serial innovator with roles at Stryker and Veran. "I'm not a…
Lung cancer is the leading cause of cancer deaths worldwide, with approximately 1.8 million people dying from lung cancer each year. The majority of patients are diagnosed after symptoms have…
Lead investor Mercia, alongside Intuitive Ventures and Black Opal, invests inOptellum’s pioneering AI-powered lung-health technology Oxford, 27 September 2022, 8am: Optellum, an Oxford-based medtech company that provides a breakthrough AI…
Optellum was founded with the vision of providing clinical decision support software that could help lung disease patients be diagnosed and treated with curative intent at the earliest possible stage.…
This payment assignment to a newly available Healthcare Common Procedure Coding System (HCPCS) code constitutes an important step towards reimbursing providers for the use of Optellum’s transformative technology with Medicare…
After gaining CE certification for its software Virtual Nodule Clinic, Optellum has attained UKCA certification under the UK’s Medical Devices Regulations. Optellum, an Oxford-based medtech company, provides breakthrough AI technologies…
Optellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union’s Medical Device Regulation. Oxford, UK – 30 March 2022:…
Optellum is referenced within the report with recommendations on how AI will be implemented and physicians trained in new technologies across the NHS Optellum has been named as one of…